Major adverse cardiovascular events in a real-life COPD patient population

被引:0
|
作者
Michotte, Naomi [1 ]
Hanon, Shane [1 ]
Verbanck, Sylvia [1 ]
Vanderhelst, Eef [1 ]
机构
[1] Univ Hosp Brussels, Jette, Belgium
关键词
D O I
10.1183/13993003.congress-2024.PA1760
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study
    Nazik Bahcecioglu, Sakine
    TURK, Murat
    ATAYIK, Emel
    PACACI CETIN, Gulden
    ARSLAN, Bahar
    GULMEZ, Inci
    YILMAZ, Insu
    ASTIM ALLERJI IMMUNOLOJI, 2022, 20 (02): : 81 - 86
  • [22] Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience
    Elbaz, Tamer
    Elserafy, Magdy
    Elakel, Wafaa
    Mohey, Mohammad A.
    Abdo, Mahmoud
    Hassany, Mohamed
    Mehrez, Mai
    Abouelkhair, Mahmoud
    Yosry, Ayman
    Omar, Ashraf
    Waked, Imam
    Elsayed, Manal Hamdy
    Mahran, Zakaria
    Elshazly, Yahia
    Elgarem, Noman
    Gaballa, Aly
    Doss, Wahid
    Esmat, Gamal
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2017, 37 (08): : 348 - 353
  • [23] A COMPARISON OF ADVERSE EVENTS ASSOCIATED WITH LICENSED AND UNLICENSED SPACER USE WITH NON-EXTRAFINE BECLOMETASONE DIPROPIONATE TREATMENT IN A REAL-LIFE PATIENT POPULATION WITH ASTHMA IN THE UK
    Ming, S. Wan Yau
    Haughney, J.
    Ryan, D.
    Patel, S.
    Ochel, M.
    Thornhill, S.
    Price, D.
    THORAX, 2017, 72 : A193 - A193
  • [24] Prediabetes and the Incidence of Major Adverse Cardiovascular Events
    Booth, Gillian L.
    Rezai, Mohammad R.
    Atzema, Clare
    Austin, Peter C.
    Bhatia, Sacha
    Bierman, Arlene S.
    Clemens, Kristin K.
    Johnston, Sharon
    Ko, Dennis T.
    Lee, Douglas S.
    Tu, Karen
    Tu, Jack V.
    DIABETES, 2017, 66 : A81 - A82
  • [25] The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study
    Gonzalez-Juanatey, Jose R.
    Cordero, Alberto
    Castellano, Jose Ma
    Masana, Luis
    Dalmau, Regina
    Ruiz, Emilio
    Sicras-Mainar, Antonio
    Fuster, Valentin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 361 : 116 - 123
  • [26] A paradigm shift for cardiovascular outcome evaluation in diabetes: Major adverse cardiovascular events (MACE) to major adverse vascular events (MAVE)
    Rastogi, Ashu
    Sudhayakumar, Anand
    Schaper, Nicolaas C.
    Jude, Edward B.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (11)
  • [27] Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease A Real-Life Investigation From Italy
    Biffi, Annalisa
    Rea, Federico
    Scotti, Lorenza
    Lucenteforte, Ersilia
    Vannacci, Alfredo
    Lombardi, Niccolo
    Chinellato, Alessandro
    Onder, Graziano
    Vitale, Cristiana
    Cascini, Silvia
    Ingrasciotta, Ylenia
    Roberto, Giuseppe
    Mugelli, Alessandro
    Corrao, Giovanni
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (02) : 112 - 121
  • [28] Lymphopenia is not associated with efficacy and risk of adverse events in a real-life MS population treated with fingo-limod and dimethyl fumarate
    Bruschi, N.
    Boffa, G.
    Cellerino, M.
    Sbragia, E.
    Novi, G.
    Lapucci, C.
    Carpaneto, S.
    Laroni, A.
    Capello, E.
    Uccelli, A.
    Inglese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 334 - 334
  • [29] EFFECT OF ACLIDINIUM BROMIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS AND EXACERBATIONS IN PATIENTS WITH COPD AND DIFFERENT CARDIOVASCULAR RISK FACTOR LEVELS
    Chapman, Kenneth
    Wise, Robert
    Scirica, Benjamin
    Schoenfeld, David
    Bhatt, Deepak
    Daoud, Sami
    Zetterstrand, Sofia
    Reisner, Colin
    Gil, Esther Garcia
    CHEST, 2018, 154 (04) : 1115A - 1117A
  • [30] Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD
    Ellis, Paul
    Bailey, Emily
    Choate, Radmila
    Holm, Kristen E.
    Sandhaus, Robert A.
    Turner, Alice M.
    Newnham, Michael
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 149 - 159